Wells Fargo & Company »

Cns Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Cns Pharmaceuticals shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Cns Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Cns Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cns Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-06-30 $6 4 1.50

More positions owned by Wells Fargo & Company

Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
UnitedHealth Call Option (UNH)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Wells Fargo & Company

Top funds holding Cns Pharmaceuticals

Frigate Ventures
Tower Research Capital
Wells Fargo & Company
Morgan Stanley
Global Retirement Partners
Plante Moran Financial Advisors
Bank of America Corporation
Parallel Advisors

View all funds holding Cns Pharmaceuticals